Description  Claims  Drawing  Cited references 

US2013184342A1   [0003] 
US7321050B   [0071] 
US6022998A   [0071] 
US6177220B   [0071] 
US5068300A   [0071] 
US3387050A   [0071] 
US5563298A   [0071] 
US7820848B   [0071] 
US8101804B   [0071] 
US6218108B   [0071] 
US7714161B   [0071] 
US20070276172A   [0071] 
US20040143023A   [0071] 
EP0834575A   [0089]  [0105] 
EP0834576A   [0089]  [0105] 
WO9631622A   [0089]  [0105] 
US5837832A   [0089]  [0105] 
WO9830883A   [0089]  [0105] 
WO9710365A   [0089]  [0105] 
US20030129665A   [0135] 
US6043082A   [0177] 
US6649595B   [0177] 
US6146885A   [0184] 
US3773919A   [0190] 
US6747014B   [0190]  [0195] 
US353270960B   [0190] 
US4837028A   [0191] 
US5543152A   [0191] 
US4426330A   [0191] 
US4534899A   [0191] 
US5013556A   [0191] 
US5356633A   [0191] 
US5213804A   [0191] 
US5225212A   [0191] 
US5540935A   [0191] 
US5556948A   [0191] 
US5264221A   [0191] 
US5665710A   [0191] 
EP0445131B1   [0191] 
EP0496813B1   [0191] 
WO8804924A   [0191] 
WO9713499A   [0191] 
WO9004384A   [0191] 
WO9105545A   [0191] 
WO9420073A   [0191] 
WO9610391A   [0191] 
WO9640062A   [0191] 
WO970478A   [0191] 
US6191105B   [0192] 
US7063860B   [0192] 
US7070802B   [0192] 
US7157099B   [0192] 
US6887906B   [0195] 
US20030027780A   [0195] 
US3845770A   [0201] 
US3916899A   [0201] 
US3536809A   [0201] 
US3598123A   [0201] 
US4008719A   [0201] 
US5674533A   [0201] 
US5059595A   [0201] 
US5591767A   [0201] 
US5120548A   [0201] 
US5073543A   [0201] 
US5639476A   [0201] 
US5354556A   [0201] 
US5733566A   [0201] 
US6365185B1   [0201] 
US8324211B   [0211] 
US8318719B   [0211] 
US8299077B   [0211] 
US8232280B   [0211] 
US8236812B   [0211] 
US7393848B   [0211] 
US7405295B   [0211] 
US7514444B   [0211] 
US7625880B   [0211] 
US7683064B   [0211] 
US7732454B   [0211] 
US7741330B   [0211] 
US7825118B   [0211] 
US7902194B   [0211] 
US7906509B   [0211] 
US7943618B   [0211] 
US7960396B   [0211] 
US8008309B   [0211] 
US8067395B   [0211] 
US8088781B   [0211] 
US8124604B   [0211] 
US20130018032A   [0211] 
US20130018060A   [0211] 
US20130035334A   [0211] 
US8093244B   [0213] 
US7560462B   [0213] 
US7550477B   [0213] 
US7501435B   [0213] 
US7485649B   [0213] 
US20070083044A   [0213] 
US20070082900A   [0213] 
US20070105864A   [0213] 
US20070117804A   [0213] 
US7737174B   [0214] 
US8288377B   [0214] 
US8222288B   [0214] 
US7834016B   [0214] 
US20110319378A   [0214] 
WO2012121662A   [0214] 
US20050250836A   [0215] 
WO2003091255A   [0215] 
US20060229289A   [0216] 
US20070259937A   [0216] 
US20120309717A   [0216] 
US20130011365A   [0216] 
US8372987B   [0216] 
US8362030B   [0216] 
US8236802B   [0216] 
US8217070B   [0216] 
US8183250B   [0216] 
US8088760B   [0216] 
WO0185686A   [0216] 
WO0042040A   [0216] 
WO0039070A   [0216] 
WO0039104A   [0216] 
WO9911623A   [0216] 
WO9911628A   [0216] 
WO9911622A   [0216] 
WO9959975A   [0216] 
WO9911644A   [0216] 
WO9911945A   [0216] 
WO9911649A   [0216] 
WO9959973A   [0216] 
US20120283238A   [0218] 
US8293923B   [0218] 

Stilbenes Synthesis and Applications   [0071] 
Stilbenes Preparation and Analysis   [0071] 
BioTechniques   [0077] 
EXCLI Journal   [0078] 
Research Journal of Applied Sciences, Engineering and Technology   [0078] 
Trends Immunol   [0084] 
Nat Rev Immunol   [0084] 
Curr Opin Immunol   [0084] 
Adv Immunol   [0084]  [0084] 
J Exp Med   [0084] 
J Biol Chem   [0084] 
Curr Opin Immunol   [0084] 
Immunol Rev   [0084] 
Nature   [0084] 
Trends Immunol.   [0084] 
Carcinogenesis   [0084] 
Mol Cell   [0084] 
Nat. Genet.   [0084] 
Proc. Natl. Acad. Sci. USA   [0084] 
J. Exp. Med.   [0084] 
Mol. Immunol.   [0084] 
J. Exp. Med.   [0084] 
J. Exp. Med.   [0084] 
Oncogene   [0084] 
Leuk Lymphoma.   [0085] 
Leukemia   [0085] 
Br J Dermatol   [0085] 
Nature   [0085] 
Blood   [0085] 
J Exp Med   [0085] 
PNAS USA   [0085] 
Appl Immunohistochem Mol Morphol   [0085] 
Cancer Cell   [0085] 
Blood   [0085] 
Mod Pathol   [0085] 
Cancer Res   [0085] 
Int J Biochem Cell Biol.   [0085] 
Leukemia   [0085] 
Cancer Sci.   [0085] 
Mod Pathol   [0085] 
BMC Cancer   [0085] 
Adv Immunol   [0085] 
Hum Pathol   [0085] 
Hepatology   [0085] 
Leukemia   [0085] 
Br J Dermatol.   [0085] 
Scand. J. Immunol.   [0086] 
Autoimmunity   [0086] 
Methods in Molecular Biology   [0089]  [0105] 
Biochemistry   [0093]  [0109] 
Curr. Top. Dev. Biol.   [0093]  [0109] 
J. Immunol. Methods   [0093]  [0109] 
Pathology and Genetics of tumors of hematopoietic and lymphoid tissues   [0134]  [0135]  [0138] 
Diagnostic Histopathology of Tumors   [0142] 
Methods of Cancer Diagnosis, Therapy and Prognosis   [0142] 
Rituximab and its Role as Maintenance Therapy in non-Hodgkin Lymphoma   [0146] 
The Therapeutic Use of Rituximab in non-Hodgkin's Lymphoma   [0146] 
Rituximab: A Review of its Use in non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia   [0146] 
The Lupus Book: A Guide for Patients and Their Families   [0159] 
Cutaneous Lupus Erythematosus   [0159] 
Systemic Lupus Erythematosus   [0159] 
Nat. Med.   [0177]  [0177] 
Proc. Natl. Acad. Sci. USA   [0177] 
Proc. Natl. Acad. Sci. USA   [0177] 
Proc. Natl. Acad. Sci. USA   [0177] 
Proc. Natl. Acad. Sci. USA   [0177] 
Viral Vector Targeting   [0182] 
Retroviral Vector Targeting for Gene Therapy   [0182] 
Targeting Adenovirus   [0182] 
Targeting Gene Therapy to Cancer: A Review   [0182] 
Strategies to Adapt Adenoviral Vectors for Targeted Delivery   [0182] 
Targeted Delivery of DNA for Gene Therapy via Receptors   [0182] 
Strategies to Accomplish Gene Delivery Via the Receptor-Mediated Endocytosis Pathway   [0183] 
Receptor-Mediated DNA Delivery Approaches to Human Gene Therapy   [0183] 
Strategies to Achieve Targeted Gene Delivery Via the Receptor-Mediated Endocytosis Pathway   [0183] 
Antiangiogenic Gene Therapy Targeting The Endothelium-Specific Receptor Tyrosine Kinase Tie2   [0183] 
Targeted Drug Delivery Via the Folate Receptor   [0183] 
Therapeutic Application of Anti-Growth Factor Receptor Antibodies   [0183] 
Receptor Mediated Glycotargeting   [0183] 
An Evaluation of Receptor-Mediated Gene Transfer Using Synthetic DNA-Ligand Complexes   [0183] 
Hepatocyte Directed Gene Delivery by Receptor-Mediated Endocytosis   [0183] 
Specific Targeting Strategies of Cancer Gene Therapy Using a Single-Chain Variable Fragment (scFv) with a High Affinity for CEA   [0184] 
In Vivo Cell Type-Specific Gene Delivery With Retroviral Vectors That Display Single Chain Antibodies   [0184] 
Targeting Human T Cells By Retroviral Vectors Displaying Antibody Domains Selected From A Phage Display Library   [0184] 
Cell-Type-Specific Gene Transfer Into Human Cells With Retroviral Vectors That Display Single-Chain Antibodies   [0184] 
Toward Highly Efficient Cell-Type-Specific Gene Transfer With Retroviral Vectors Displaying Single-Chain Antibodies   [0184] 
Retroviral Vector Particles Displaying The Antigen-Binding Site Of An Antibody Enable Cell-Type-Specific Gene Transfer   [0184] 
Cell Targeting With Retroviral Vector Particles Containing Antibody-Envelope Fusion Proteins   [0184] 
Ann. Rev. Pharmacol. Toxicol.   [0190] 
Controlled Release of Pesticides and Pharmaceuticals   [0190] 
Biochem. Biophys. Res. Commun.   [0191] 
Journal of Controlled Release   [0191] 
S.T.P.Pharma. Sci.   [0191] 
FEBS Letters   [0191] 
Cancer Research   [0191] 
Ann. N.Y. Acad. Sci.   [0191] 
PNAS   [0191] 
FEBS Lett.   [0191] 
Bull. Chem. Soc. Jpn.   [0191] 
FEBS Lett.   [0191] 
Biochimica et Biophysica Acta   [0191] 
Methods Mol Biol.   [0191] 
Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems   [0192] 
Pharmaceutical Dosage Forms   [0192] 
Pharmaceutical Dosage Forms   [0192] 
Block in Pharmaceutical Dosage Forms   [0192] 
Remington's Pharmaceutical Sciences   [0192] 
Controlled Release of Drugs: Polymers and Aggregate Systems   [0192] 
Remington's Pharmaceutical Sciences   [0192] 
Pharmaceutical Research   [0192] 
Meth. Find. Exp. Clin. Pharmacol.   [0192] 
J. Pharm. Sci.   [0192] 
Critical Reviews in Therapeutic Drug Carrier Systems   [0192]  [0194] 
Pharmaceutical Dosage Forms   [0193]  [0193] 
Surfactants and polymers in drug delivery   [0194] 
J. Pharm. Pharmacol.   [0194] 
Enhancement in Drug Delivery   [0194] 
Critical Reviews in Therapeutic Drug Carrier Systems   [0194] 
J. Pharm. Pharmacol.   [0194] 
Goodman & Gilman's The Pharmacological Basis of Therapeutics   [0194] 
Remington's Pharmaceutical Sciences   [0194] 
J. Pharm. Exp. Ther.   [0194] 
J. Pharm. Sci.   [0194] 
J. Chromatogr.   [0194] 
Excipient development for pharmaceutical, biotechnology, and drug delivery   [0194] 
J. Control Rel.   [0194] 
Controlled Release Dosage Form Design   [0199] 
Pharmaceutical Salts   [0208] 
Handbook of Pharmaceutical Salts: Properties, Selection and Use   [0208] 
J. Biol. Chem.   [0211] 
The EMBO Journal   [0215] 
Cancer Biology & Therapy   [0215] 
Cancer Research   [0215] 
J. Med. Chem.   [0216] 
J. Med. Chem.   [0216] 
Anti-Cancer Agents in Medicinal Chemistry   [0216] 
Curr Opin. Investigational Drugs   [0216] 
Nature Biotechnology   [0216] 
Nature Reviews Cancer   [0216] 
Mol Cancer Ther   [0216] 
Chem. Med. Chem   [0216] 
J Med Chem   [0216] 
Invest New Drugs   [0216] 
J. Med. Chem.   [0216] 
J. Exp. Med.   [0218] 
J. Biomol. Screen.   [0218] 
Biochem. J.   [0218] 
Mol. Immunol.   [0218] 
The Merck Manual of Diagnosis and Therapy   [0292] 
The Encyclopedia of Molecular Biology   [0292] 
Genes X   [0292] 
Molecular Biology and Biotechnology: a Comprehensive Desk Reference   [0292] 
Current Protocols in Protein Sciences   [0292] 
Molecular Cloning: A Laboratory Manual   [0293] 
Basic Methods in Molecular Biology   [0293] 
Methods in Enzymology: Guide to Molecular Cloning Techniques   [0293] 
Current Protocols in Protein Science (CPPS)   [0293] 
Current Protocols in Cell Biology (CPCB)   [0293] 
Culture of Animal Cells: A Manual of Basic Technique   [0293] 
Animal Cell Culture Methods (Methods in Cell Biology   [0293] 
Inducing Synthetic Lethality using PARP Inhibitors   [0337] 
Homologous Recombination Is Necessary for Normal Lymphocyte Development   [0337] 
Hormetic mechanisms   [0337] 
AIDing antibody diversity by error-prone mismatch repair   [0337] 
Transcription-targeted DNA deamination by the AID antibody diversification enzyme   [0337] 
Second Malignancies as a Consequence of Nucleoside Analog Therapy for Chronic Lymphoid Leukemias   [0337] 
DNA double-strand break repair signalling: The casse of RAD51 post-translational regulation   [0337] 
Studies on Human Leukemic Cels in Vitro   [0337] 
The DNA Damage Response: Ten Years After   [0337] 
Activation-Induced cytidine deaminase-initiated off-target DNA breaks are detected and resolved during S phase   [0337] 
Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination   [0337] 
High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia   [0337] 
Subamolide A Induces Mitotic Catastrophe Accompanied by Apoptosis in Human Lung Cancer Cells   [0337] 
DIDS, a chemical compound that inhibits RAD51-mediated homologous pairing and strand exchange   [0337] 
Role of recA/RAD51 Family Proteins in Mammals   [0337] 
The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia   [0337] 
Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis   [0337] 
Use of cyclophosphamide as a positive control in dominant lethal and micronucleus assays   [0337] 
Attenuating homologous recombination stimulates an AID-induced antileukemic effect   [0337] 
Sister Chromatid Exchange Analysis   [0337] 
AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib   [0337] 
Alternative Lengthening of Telomeres Is Characterized by High Rates of Telomeric Exchange   [0337] 
Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation   [0337] 
Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies   [0337] 
BRCA2 is required for homology-directed repair of chromosomal breaks   [0337] 
Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme   [0337] 
Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity   [0337] 
Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair   [0337] 
Constitutive Expression of AID Leads to Tumorigenesis   [0337] 
High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease   [0337] 
AID is required for germinal center-derived lymphomagenesis   [0337] 
Skin lesions in chronic lymphocytic leukemia   [0337] 
AID Produces DNA Double-Strand Breaks in Non-Ig Genes and Mature B Cell Lymphomas with Reciprocal Chromosome Translocations   [0337] 
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data   [0337] 
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells   [0337] 
Non-Apoptotic Responses to Anticancer Agents: Mitotic Catastrophe, Senescence, and the Role of p53 and p21   [0337] 
Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis   [0337] 
Aberrant expression and mutation-inducing activity of AID in human lung cancer   [0337] 
Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein   [0337] 
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation   [0337] 
Activation-Induced Cytidine Deaminase Induces Reproducible DNA Breaks at Many Non-Ig Loci in Activated B Cells   [0337] 
The Sister Chromatid Exchange (SCE) Assay   [0337] 
DNA strand exchange mediated by a RAD51-ssDNA nucleoprotein filament with polarity opposite to that of RecA   [0337] 
RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesis   [0337] 
The RAD51 gene family, genetic instability and cancer   [0337] 
AID- and Ung-dependent generation of staggered double-strand DNA breaks in immunoglobulin class switch DNA recombination: A post-cleavage role for AID   [0337]